ALTEIKA-TERNOPHARM
UkraineThe drug is used for the complex treatment of acute and chronic inflammatory diseases of the respiratory tract, such as laryngitis, tracheitis, bronchitis, bronchial asthma, and whooping cough.
Frequently asked questions
How should Alteika-ternopharm be taken correctly?
The syrup should be taken before meals. Adults and children aged 14 years and older should take 15 ml 4–6 times a day. Children aged 6–14 years should take 10 ml 4–6 times a day, and children aged 2 to 6 years should take 5 ml 4–6 times a day (the dose for children aged 2–6 years should be diluted in 10–15 ml of boiled water).
What are the possible side effects of Alteika-ternopharm?
Allergic reactions, irritation of the gastric mucosa, or increased salivation are possible. If you notice any adverse reactions, you should discontinue treatment and consult a physician.
Who should not take this drug?
The drug should not be used in case of hypersensitivity to its components.
Can this product be combined with other medicines?
It is not recommended to take this drug simultaneously with antitussive agents, such as codeine.
Can the drug be taken by pregnant or breastfeeding women?
Use during this period is not recommended, as information regarding the experience of using the drug in such cases is unavailable.
How long should the course of treatment last?
The duration of the course is determined by a physician depending on the results; it usually lasts from 7 to 14 days.
Instructions for use
INSTRUCTIONS FOR MEDICINAL USE OF THE MEDICINAL PRODUCT Alteika-Ternofarm
Composition:
Active substance: dry extract of marshmallow root (4:1);
5 ml of syrup contain dry extract of marshmallow root (Althaeae radix extractum siccum) (4:1) (extractant – water), calculated as polysaccharides 7.5 mg;
Excipients: sodium methylparaben (E 219), sodium propylparaben (E 217), citric acid monohydrate, confectioner's sugar, purified water.
Pharmaceutical form. Syrup.
Main physicochemical properties: syrup-like liquid, light brown to reddish-brown in color, with a specific odor. Sediment formation may occur during storage.
Pharmacotherapeutic group.
Preparations used for cough and colds. Expectorants. Marshmallow roots.
ATC code R05C A05.
Pharmacological properties.
Pharmacodynamics. Direct-acting expectorant. A herbal preparation whose main active ingredients are polysaccharides, as well as pectins, amino acids, starch, etc. The polysaccharides of the preparation are absorbed into the blood, partially excreted by the bronchial glands, and exert a coating, softening, and anti-inflammatory effect on the mucous membrane of the upper respiratory tract. They somewhat increase the secretion of the liquid component of bronchial mucus and normalize its rheological properties (viscosity, elasticity, adhesiveness). Enhances peristaltic movements of bronchioles and motor function of the ciliated epithelium of the bronchi, promoting the expulsion of sputum.
Pharmacokinetics. Not studied.
Clinical characteristics.
Indications.
Complex treatment of acute and chronic inflammatory diseases of the respiratory tract: laryngitis, tracheitis, bronchitis, bronchial asthma, pertussis.
Contraindications.
Hypersensitivity to the components of the medicinal product.
Interaction with other medicinal products and other types of interactions.
Concomitant use with antitussive agents (e.g., codeine) is not recommended.
Special precautions for use
The presence of sodium methylparaben (E 219) and sodium propylparaben (E 217) in the medicinal product may cause allergic reactions (possibly delayed).
Use during pregnancy or breastfeeding
The medicinal product should not be used, as there is no information available regarding experience with the use of the drug during pregnancy or breastfeeding.
Ability to affect reaction rate while driving or operating machinery
The use of the drug generally does not affect reaction speed while driving or operating machinery.
Dosage and Administration.
The medicine should be taken before meals.
Adults and children aged 14 years and older: 15 ml of syrup 4–6 times daily.
Children aged 6–14 years: 10 ml of syrup 4–6 times daily.
Children aged 2–6 years: 5 ml of syrup 4–6 times daily.
For children aged 2 to 6 years, the prescribed dose of syrup should be diluted in a sufficient amount of boiled water (10–15 ml).
The duration of treatment is determined individually by a physician according to therapeutic response and usually lasts 7–14 days.
Children.
The medicine is indicated for children aged 2 years and older.
Overdose.
Cases of overdose have not been reported.
Side effects.
Allergic reactions, increased salivation, and irritation of the gastric mucosa are possible. If any adverse reactions occur, discontinue treatment with the medication and consult a physician.
Shelf life.
2 years.
Storage conditions.
Store in the original packaging at a temperature not exceeding 25 °C.
After opening, store for no more than 14 days at a temperature not exceeding 25 °C.
Keep out of reach of children.
Packaging.
100 ml or 200 ml in a bottle; 1 bottle with a measuring spoon or measuring cup in a carton.
Availability.
Over-the-counter.
Manufacturer/Applicant.
TOV "Ternofarm".
Manufacturer's location and address of business activity / Applicant's location.
46010, Ternopil, Fabrychna St., 4, Ukraine.
Tel./Fax: (0352) 521-444, www.ternopharm.com.ua
Similar drugs
| Brand name | Dosage form | Active substance / Dosage | Manufacturer |
|---|---|---|---|
| ALTEIKA HALYCHPHARM | syrup |
|
PJSC "Halychpharm" |
| ALTEMIX | syrup |
|
LLC "Corporation "Zdorovya" (all manufacturing stages, quality control, batch release) |
| ALTHEA ROOT SYRUP | syrup |
|
PJSC Pharmaceutical Factory "Viola" |
| MUCALTIN | syrup |
|
PJSC "Galychfarm" (all manufacturing stages except primary packaging into sachets) |
The original data is available in the language of the country of manufacture.
Data source: State Register of Medicinal Products of Ukraine
Data last verified: August 13, 2026